Media-OutReach Newswire Abivax receives ANSM and Ethics Committee clearance to test its development candidate ABX464 in 1,034 Covid-19 patients in randomized Phase 2b/3 clinical trial
Media-OutReach Newswire Hugill & Ip Adds a Red Ribbon to its Logo, Further Strengthening its Social Responsibility Commitment following the Launch of "Wills of Concern"